Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers. - Wikidata - wikimedia - TriplyDB

Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.

Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.

http://www.wikidata.org/entity/Q35924777

about

Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial.Salvianolic acid B inhibits growth of head and neck squamous cell carcinoma in vitro and in vivo via cyclooxygenase-2 and apoptotic pathways Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention.Targeting the eicosanoid pathway in non-small-cell lung cancer.Inactivating mutation in the prostaglandin transporter gene, SLCO2A1, associated with familial digital clubbing, colon neoplasia, and NSAID resistance.Pathogenetic mechanisms in gastric cancer.Urinary prostaglandin E2 metabolite and breast cancer risk.Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology.Urinary prostaglandin E2 metabolite and pancreatic cancer risk: case-control study in urban Shanghai A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoids Urine Eicosanoids in the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial.Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer.Association between urinary prostaglandin E2 metabolite and breast cancer risk: a prospective, case-cohort study of postmenopausal women.Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer.Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapy Phase II study of celecoxib and docetaxel in non-small cell lung cancer (NSCLC) patients with progression after platinum-based therapy Urinary PGE-M: a promising cancer biomarker Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway.Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients.A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk.Impact of hypertrophic pulmonary osteoarthropathy on patients with lung cancer.Simultaneous and high-throughput quantitation of urinary tetranor PGDM and tetranor PGEM by online SPE-LC-MS/MS as inflammatory biomarkers.

P2860

Q33759853-092C57E2-53FA-460A-8A57-4DD9AE3F4BE6 Q33769748-7DC9F366-F826-48A9-8D65-5BE3E2657513 Q33936367-9853D039-202F-4C12-B404-E245D4C37657 Q33936807-E298E1FC-8918-4F7E-A25B-F4EDA759EED1 Q34017114-84E9BEBA-084C-4681-8D90-56F1C0C6713C Q34326627-EF35D008-2391-426A-A648-7E96D84D1E33 Q34641787-54D9FA0A-6C8D-44AD-8BDF-6B156EBF294A Q34952213-A30F4DA5-14A7-4729-80AB-0B91410B8469 Q35094999-97454862-2F31-4ABD-B171-CFBF5244D5D9 Q35897007-D4111676-831A-4284-AAEF-3AC10FBB27C8 Q36258777-E2008818-5D2A-42FE-B8D7-62B091A448D6 Q36892544-75D75B0E-4BE6-4A4A-A4B4-58DF8BECA4CE Q36916609-652441B1-3FB0-4D8E-AE29-2A6BD0F828B0 Q37119166-4386D627-A2A6-4D34-A8C1-91774545FDFC Q37155953-D7010444-97CE-44F1-BACB-4D1B3AFE8797 Q37166270-961BABDC-11D3-4F5F-855A-CDA9E37147EC Q37166867-DEFD94FA-4513-41FB-8C17-FAA26C55A4B1 Q37349830-18E1FA3C-A8C9-4966-9C8F-3B2CFFD99487 Q37442352-654800ED-E30D-4677-8433-4A004116ED8A Q40246172-1A6AE0AA-E9C4-43BC-8B06-AA311A03E3C2 Q47145084-18AA98B6-58BA-4FBA-9689-C4BBF06FEB15 Q53085976-FD91C4F4-A0F1-49A8-958E-5B6A8F7A410D

P2860

Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers.

http://www.wikidata.org/entity/Q35924777

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Levels of prostaglandin E meta ...... E2, are increased in smokers.

@ast

Levels of prostaglandin E meta ...... E2, are increased in smokers.

@en

type

label

Levels of prostaglandin E meta ...... E2, are increased in smokers.

@ast

Levels of prostaglandin E meta ...... E2, are increased in smokers.

@en

prefLabel

Levels of prostaglandin E meta ...... E2, are increased in smokers.

@ast

Levels of prostaglandin E meta ...... E2, are increased in smokers.

@en

P1433

Q35924777-05466699-D01E-4889-BCE3-0C7EDADB8221

P1476

Q35924777-93223306-8BDE-4E03-AB45-E9AB86B212F7

P2093

Q35924777-08AD4253-2B17-4DBE-9280-698909C8B3EC

Q35924777-8590C3FE-C64D-4496-A3DD-48483D7A5E6C

Q35924777-B1492E10-F289-4AB0-9EC6-C76A041F15D9

Q35924777-B901C1D9-730B-4EFE-AAC1-451D4F0BD988

Q35924777-B955461F-AB87-4D78-BDBC-278645CBF207

Q35924777-C3B52F7E-E6C6-4162-84C2-A33E5A29C33A

Q35924777-E1A1C2FC-0628-4078-9D96-5FB782AD2843

Q35924777-FF65C765-366B-422B-A1EF-9BABC44CD136

P2860

Q35924777-0289ABE9-7DDB-41BA-816F-5B35C4104299

Q35924777-02CFF481-3828-46BF-9D67-F0E2917471AC

Q35924777-03E6E464-3911-4761-A085-9546E368C587

Q35924777-051CAE2D-7CA1-45F8-90A6-1E472F03EDD1

Q35924777-10372248-B31E-4DF7-BFC0-029034A0D141

Q35924777-12B7C172-B135-43B3-AC52-6A3B41B822C6

Q35924777-1C3A0B17-9E4A-4DBD-8F20-1FFB7536D526

Q35924777-241B2C54-EE02-411F-BF99-8923EDF57BAA

Q35924777-2E8B47E9-B630-4F9E-B7BF-47E95B34AE79

Q35924777-2F6208FF-BEAE-4DE8-A028-A608EE5F6456

P304

Q35924777-7303674C-E25F-4F7A-A3BA-65C216E3E840

P31

Q35924777-0C4285C6-D0B9-4763-9832-8E3F72650AC8

P356

Q35924777-AC234539-DFDF-4E3C-92B2-3BB1E283BBF1

P407

Q35924777-D75D08FA-C01D-4239-8ED3-43403E43B176

P433

Q35924777-C04DC5EE-BB9F-496A-BD70-364A7A19AC42

P478

Q35924777-42D33E31-5554-4F76-8EBC-EFBE3476053F

P577

Q35924777-7F7F92FD-479D-4E42-8DF4-8264245CDCB6

P698

Q35924777-72E4FA29-2A74-406B-BC2E-9923156381F6

P932

Q35924777-7AB21CC2-D6FF-419D-A26F-3C52F45A89BD

P356

1078-0432.CCR-05-0733

P1433

Clinical Cancer Research

P1476

Levels of prostaglandin E meta ...... E2, are increased in smokers.

@en

P2093

Andrew J Dannenberg

http://www.w3.org/2001/XMLSchema#string

Anna J Duffield-Lillico

http://www.w3.org/2001/XMLSchema#string

Chaya S Moskowitz

http://www.w3.org/2001/XMLSchema#string

Jason D Morrow

http://www.w3.org/2001/XMLSchema#string

Jay O Boyle

http://www.w3.org/2001/XMLSchema#string

Kotha Subbaramaiah

http://www.w3.org/2001/XMLSchema#string

Myles K Williams

http://www.w3.org/2001/XMLSchema#string

Neil D Gross

http://www.w3.org/2001/XMLSchema#string

P2860

Tobacco and cancer: recent epidemiological evidence

Quantifications of the major urinary metabolite of the E prostaglandins by mass spectrometry: evaluation of the method's application to clinical studies

Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk.

Tobacco carcinogens, their biomarkers and tobacco-induced cancer.

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise.

Phases of biomarker development for early detection of cancer.

Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer.

Levels of cyclooxygenase-2 are increased in the oral mucosa of smokers: evidence for the role of epidermal growth factor receptor and its ligands.

Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper

P304

6087-6093

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-05-0733

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16115954

http://www.w3.org/2001/XMLSchema#string

P932

1939807

http://www.w3.org/2001/XMLSchema#string